OSCR

Therapeutic Advances in Major NBIA Disorders: Current Strategies and Translational Challenges.

Overview

  1. Unit of Medical Genetics and Neurogenetics, Fondazione IRCCS Istituto Neurologico Carlo Besta, 20126 Milan, Italy; (F.C.); (G.G.); (V.T.)
Journal: Neurology international, volume 18, issue 7, article 133
Dates: received 11 June 2026; accepted 9 July 2026; published online 10 July 2026
Type: Review · Language: English
License: CC BY
Identifiers: DOI 10.3390/neurolint18070133 · PMID 42506055 · PMCID PMC13414613 · OpenAlex W7167933087
Open access: gold, a free copy (OpenAlex)
Status: code verified (how the code is found and verified)
Categories: other condition (population), clinical / translational (subfield)
Methods: Spectral & time-frequency, fMRI & imaging
Keywords: PKAN, CoPAN, PLAN, BPAN, MPAN, Neurodegeneration with brain iron accumulation, lipid metabolism, autophagy, CoA biosynthesis
Topic: Neurological diseases and metabolism (Neurology, Neuroscience), according to OpenAlex
Funding: Ministero della Salute (RRC)
Citations: cited by 1 paper (Europe PMC); 180 references in the paper

Abstract

Neurodegeneration with brain iron accumulation (NBIA) comprises a group of rare genetic movement disorders characterized by progressive neurological deterioration, dystonia, parkinsonism, spasticity, and abnormal iron deposition in the basal ganglia. Although iron accumulation is the shared neuroradiological hallmark, most NBIA genes do not directly regulate iron metabolism. Instead, major NBIA forms arise from disruption of distinct but converging cellular pathways, including coenzyme A (CoA) biosynthesis, lipid metabolism, mitochondrial function, and autophagy. This narrative review aims to examine the pathogenic mechanisms of major NBIA disorders, namely pantothenate kinase-associated neurodegeneration (PKAN), COASY protein-associated neurodegeneration (CoPAN), PLA2G6-associated neurodegeneration (PLAN), mitochondrial membrane protein-associated neurodegeneration (MPAN), and beta-propeller protein-associated neurodegeneration (BPAN), and how these insights are guiding therapeutic development. Preclinical strategies aimed at restoring CoA metabolism, improving mitochondrial function, limiting lipid peroxidation, modulating autophagy, or correcting the underlying genetic defect have shown encouraging results, although none have yet reached robust clinical validation. Clinical translation remains limited by disease rarity, clinical heterogeneity, absence of validated biomarkers, and preclinical models that only partially recapitulate human pathology. Advancing the field will depend on earlier molecular diagnosis, biomarkers capable of tracking disease stage, and trial designs suited to ultra-rare populations. NBIA thus offers a paradigm for how mechanistic classification of a genetically defined disease group can redirect therapeutic strategy away from a shared radiological feature and toward pathway-specific intervention.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

No file of the authors' code could be read here: it is described below, and read at its source.

ec.europa.eu/health/documents

License: none: the authors keep all their rights
State: the link answers, verified on 27 September 2026
Evidence: the link answers
Software Heritage: not checked
Found in: the text, “AAV-Mediated Gene Replacement”
Not found: README, license file, CITATION.cff, environment file, tests, continuous integration, documentation
Availability: 1 check, the latest on 27 September 2026: the link answers (HTTP 200)
  • 27 September 2026: the link answers (HTTP 200)

Tracing map

Proposed by the machine: these links were found in the paper and verified at the source, without human review. The map will receive a Zenodo DOI once one of the paper's authors has validated it with their ORCID.

What the map holds:

  • 1 repository of the authors' code, each at its verified commit, with its license and how the link was found in the paper;
  • 0 scripts, each with its path and the digest of its content;
  • no match between paragraphs and code yet;
  • neither the text of the paper nor the code itself.

Its JSON (tracing-map.json) is deposited on Zenodo with its DOI once the map is validated.

Data

No dataset and no data link were found in the paper.

Data Availability Statement

No new data were created or analyzed in this study. Data sharing is not applicable to this article.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 27 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 4 authors, 9 keywords, 1 funder, 179 references.

Cite

This paper

Cascone, F., Gasparini, G., Tiranti, V., & Di Meo, I. (2026). Therapeutic Advances in Major NBIA Disorders: Current Strategies and Translational Challenges. Neurology international, 18(7), 133. https://doi.org/10.3390/neurolint18070133

BibTeX

@article{cascone2026therapeutic,
author = {Cascone, Floriana and Gasparini, Gemma and Tiranti, Valeria and Di Meo, Ivano},
title = {{Therapeutic Advances in Major NBIA Disorders: Current Strategies and Translational Challenges}},
journal = {Neurology international},
year = {2026},
month = jul,
volume = {18},
number = {7},
pages = {133},
publisher = {Multidisciplinary Digital Publishing Institute (MDPI)},
issn = {2035-8385},
doi = {10.3390/neurolint18070133},
url = {https://doi.org/10.3390/neurolint18070133},
pmid = {42506055},
pmcid = {PMC13414613}
}

RIS

TY - JOUR
AU - Cascone, Floriana
AU - Gasparini, Gemma
AU - Tiranti, Valeria
AU - Di Meo, Ivano
TI - Therapeutic Advances in Major NBIA Disorders: Current Strategies and Translational Challenges
T2 - Neurology international
J2 - Neurol Int
PY - 2026
DA - 2026/07/10
VL - 18
IS - 7
SP - 133
SN - 2035-8385
PB - Multidisciplinary Digital Publishing Institute (MDPI)
DO - 10.3390/neurolint18070133
UR - https://doi.org/10.3390/neurolint18070133
LA - en
ER -

CSL-JSON

{
"id": "10.3390/neurolint18070133",
"type": "article-journal",
"title": "Therapeutic Advances in Major NBIA Disorders: Current Strategies and Translational Challenges",
"container-title": "Neurology international",
"author": [
{
"family": "Cascone",
"given": "Floriana"
},
{
"family": "Gasparini",
"given": "Gemma"
},
{
"family": "Tiranti",
"given": "Valeria"
},
{
"family": "Di Meo",
"given": "Ivano"
}
],
"container-title-short": "Neurol Int",
"volume": "18",
"issue": "7",
"page": "133",
"DOI": "10.3390/neurolint18070133",
"PMID": "42506055",
"PMCID": "PMC13414613",
"ISSN": "2035-8385",
"publisher": "Multidisciplinary Digital Publishing Institute (MDPI)",
"URL": "https://doi.org/10.3390/neurolint18070133",
"language": "en",
"issued": {
"date-parts": [
[
2026,
7,
10
]
]
}
}

The tracing map gets a citation of its own once an author has validated it and it has a DOI.

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.3389/fncel.2024.1458475
CoA synthase plays a critical role in neurodevelopment and neurodegeneration.
Journal: Frontiers in cellular neuroscience
In common: other condition, 13 references, 3 authors
[2] doi:10.3390/pharmaceutics15010202
PPAR Gamma Agonist Leriglitazone Recovers Alterations Due to Pank2-Deficiency in hiPS-Derived Astrocytes.
Journal: Pharmaceutics
In common: 16 references, 2 authors
[3] doi:10.1002/acn3.52079
Emerging variants, unique phenotypes, and transcriptomic signatures: an integrated study of COASY-associated diseases.
Journal: Annals of clinical and translational neurology
In common: 11 references, 2 authors
[4] doi:10.1038/s41419-022-04626-x
Massive iron accumulation in PKAN-derived neurons and astrocytes: light on the human pathological phenotype.
Journal: Cell death & disease
In common: other condition, 9 references, 2 authors
[5] doi:10.1016/j.ebiom.2022.103869
Lifetime risk of autosomal recessive neurodegeneration with brain iron accumulation (NBIA) disorders calculated from genetic databases.
Journal: EBioMedicine
In common: other condition, 14 references
[6] doi:10.1038/s41419-024-06757-9
Mitochondrial iron deficiency triggers cytosolic iron overload in PKAN hiPS-derived astrocytes.
Journal: Cell death & disease
In common: other condition, 13 references
[7] doi:10.1186/s13023-023-02780-9
Phenotype and genotype heterogeneity of PLA2G6-associated neurodegeneration in a cohort of pediatric and adult patients.
Journal: Orphanet journal of rare diseases
In common: clinical / translational, other condition, 8 references
[8] doi:10.3389/fnins.2025.1545004
Mutation in <i>Wdr45</i> leads to early motor dysfunction and widespread aberrant axon terminals in a beta-propeller protein associated neurodegeneration (BPAN) patient-inspired mouse model.
Journal: Frontiers in neuroscience
In common: 8 references
[9] doi:10.1016/j.celrep.2022.111124
Pathological mitophagy disrupts mitochondrial homeostasis in Leber's hereditary optic neuropathy.
Journal: Cell reports
In common: other condition, 1 reference, 2 authors
[10] doi:10.3390/ijms26136197 [code]
Neuroferritinopathy Human-Induced Pluripotent Stem Cell-Derived Astrocytes Reveal an Active Role of Free Intracellular Iron in Astrocyte Reactivity.
Journal: International journal of molecular sciences
In common: 6 references

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Add the badge to the code's README

OSCR: the badge of this paper

If you are an author or a maintainer of this paper's code, you can add this badge. It says what OSCR knows of the paper (its code, its validated tracing map) and links the code to this page. Paste one of these snippets under the README's title. Keep the two marks around it, so that the badge can be replaced in place and is never added twice. OSCR changes nothing in your repository.

Markdown
<!-- oscr-badge:start -->
[![OSCR](https://openscicode.org/badge/doi/10.3390/neurolint18070133.svg)](https://openscicode.org/badge/doi/10.3390/neurolint18070133)
<!-- oscr-badge:end -->
reStructuredText
.. oscr-badge:start

.. image:: https://openscicode.org/badge/doi/10.3390/neurolint18070133.svg
   :target: https://openscicode.org/badge/doi/10.3390/neurolint18070133
   :alt: OSCR

.. oscr-badge:end
HTML
<!-- oscr-badge:start -->
<a href="https://openscicode.org/badge/doi/10.3390/neurolint18070133"><img src="https://openscicode.org/badge/doi/10.3390/neurolint18070133.svg" alt="OSCR"></a>
<!-- oscr-badge:end -->

If you choose to, you can have the badge kept up to date for you, with oscr badge --write from the command line or with the GitHub Action in your repository's workflows. Every other form and option (a card, AsciiDoc, LaTeX, shields.io) is on the badge page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Report a mismatch between the code and the paper · Report a code error (signed in)

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Report a reproduction failure (signed in)

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.